Some biological activities displayed by trehalose-6,6'-dimycolate (cord factor), a glycolipid extractable from mycobacterium, are similar to those of living BCG. Both, after intravenous (i.v.) injection into mice, induce in their lungs granulomas composed of epitheloid cells, macrophages, and lymphocytes (4) . Administration of cord factor or BCG into the footpads of mice causes formation of granulomas, marked hyperplasia of the lymphoid tissue in the paracortical zone, and accumulation of macrophages in the draining lymph nodes (5) . Mice injected with both agents into their footpads react with an increased antibody response to an unrelated antigen, subsequently injected into the same site. This increased antibody formation has been related to the granulomatous reaction induced in the draining lymph nodes. It has become evident that administration of sheep red blood cells emulsified in incomplete Freund adjuvant containing 5 ,g of cord factor induces a stronger antibody response than administration of the same antigen in Freund complete adjuvant (9) . Mice with lung granulomas induced by cord factor were protected against i.v. challenge with the virulent H37Rv strain of Mycobacterium tuberculosis, a protection similar to that observed by others after i.v. injection of intact mycobacterial cells (4, 31, 33) .
Recently, it has been found that cord factor suppresses the development of urethan-induced tumors in the lungs of mice to an extent similar to that caused by living BCG, this apparently being due to the granulomatous reaction induced in the lungs of the mice by both agents (6) .
It was observed that cord factor activates peritoneal macrophages of mice in vivo as judged by an increased acid phosphatase activity and increased phagocytic activity of Listeria monocytogenes. This activation was comparable to that induced by heat-killed or living BCG (E. Yarkoni and A. Bekierkunst, manuscript in preparation). Living BCG bacilli are able to stimulate the immunological response of the host, as evident in nonspecific resistance to heterologous bacterial infections as well as to grafted tumors of animals sensitized with BCG (7, 10, 21, 26, 27, 29) . It is also evident in suppression and regression of intradermal tumors and prevention of their metastases in guinea pigs by injection of living BCG into the tumors (33, 34, 36) . Relevant to the above activities of BCG are also the observations that experimental leukemia can be cured in some cases (2) and that remissions of human leukemia can be prolonged, as well as skin tumors of humans cured with BCG (24, 25) .
The biological activities of BCG are connected with the inflammatory chronic granulomatous reaction on the part of the host, at the site of lodgment of the bacilli. One of the components responsible for this inflammatory reaction is cord factor. It has been shown in a preliminary study that cord factor and its synthetic analogues, which are also granulomagenic, inhibit the growth of Ehrlich ascites tumor cells (EAC) in mice pretreated with these agents (30) . This study compares the effect of cord factor on growth inhibition of EAC to that displayed by BCG. ---000-0-000-0-00OO0000000 effect of cord factor. The latter injected i.v. has no inhibitory effect on the growth of the tumor cells injected i.p. To exert the inhibitory effect, both cord factor and the challenge must be injected into the same site. The results obtained with cord factor were comparable to those obtained with Calmette-Guerin bacilli in all respects, including the necessity for peritoneal pretreatment with BCG and administration of the challenge tumor cells into the same site.
The inhibition of growth of the tumor cells raises the question: What kind of host mechanism limits the growth of tumor cells or destroys them? The most plausible explanation seems to be the inflammatory reaction induced at sites of administration of cord factor or BCG. However, not every kind of inflammatory reaction is sufficient to inhibit the growth of tumor cells. Administration of emulsion alone, for instance, is not enough to create conditions limiting the growth of tumor cells. Both cord factor and BCG are able to activate peritoneal macrophages in vivo as judged by increased acid phosphatase and phagocytic activities (11, 12; E. Yarkoni and A. Bekierkunst, manuscript in preparation). Studies on other host tumor relationships suggested that macrophages may be important in rejecting tumors (3, 13, 16, 17) . However, there is a difference in the mode of action of cord factor and BCG. The latter is able to activate macrophages not only directly (E. Yarkoni and A. Bekierkunst, manuscript in preparation) but also through the intermediary products of sensitized lymphocytes during the BCG infection. Such activated macrophages may play an important role in increased resistance to autochthonous and transplanted tumors (18, 19, 22, 23) .
Cord factor alone is unable to sensitize, but as part of the BCG cell wall may cause granulomatous hypersensitivity (8) . The latter cellular reaction seems to be important in the mode of action of BCG in tumor suppression and tumor regression (14, 15) . As demonstrated clearly in a number of studies (6, 8, 33, 34, 36) , the location of BCG cells is critical. This is apparently due to the fact that. at the site of location of Calmette-Guerin bacilli and their multiplication, they elicit a chronic inflammatory granulomatous response in which there is a direct activating action on local macrophages with a gradual development of a specific immunological process which is finally expressed in specific cellular immunity. Both ways of action are apparently important in tumor suppression.
Understanding of the mode of action of BCG or components of BCG (20, 35 ) may lead to a better strategy in using BCG in cancer therapy.
The similar activities of cord factor and BCG as shown in this study and in others (4, 5, 6, 8, 9) indicate that cord factor is at least one of the components of the BCG cell wall, which is responsible for some of the biological activities of BCG. For several years now our laboratory has been involved in studies to determine the components which may be responsible for the activities of BCG. Recently it has been found that besides cord factor two other components of the mycobacterial cell wall are important in tumor suppression and regression, namely, a delipidated and deproteinized cell wall fraction and a product of lysozyme treatment of the latter, received from the strain of M. tuberculosis strain H37Ra.
The latter fraction is similar to that obtained by others from Mycobacterium smegmatis (1) . Studies on the suppression and regression of tumors in syngeneic guinea pigs with the above components of the cell wall are under way.
